Teva, Allergan Generics: FTC Worried About A Multitude Of Markets, Not A Behemoth
Executive Summary
Record-setting divestment order driven by sheer number of products where firms competed, not size of company that would result from acquisition.
You may also be interested in...
Pharma Merger Divestitures: Some Buyers Fail To Replace Generic Products
US FTC analysis of merger remedy orders finds that of 42 on-market generic products that required manufacturing transfer, the buyer was unable to continue to sell 15 products.
Pharma Merger Divestitures: Some Buyers Fail To Replace Generic Products
US FTC analysis of merger remedy orders finds that of 42 on-market generic products that required manufacturing transfer, the buyer was unable to continue to sell 15 products.
Generic Industry Consolidation Illustrated In ANDA Holder List
Most of US FDA's approved ANDAs are owned by a handful of firms, while the vast majority of owners have between one and five.